Targeted BTK inhibitors are transforming cancer treatment with advanced precision. BRUKINSA Capsule in India is designed to enhance therapeutic outcomes for B-cell malignancies by selectively inhibiting BTK pathways. Available in Delhi, it offers a promising approach for modern oncology care. Impomed Healthcare ensures accessibility to innovative treatment solutions, supporting better patient outcomes. For more information visit: https://www.impomedhealthcare.com